 placebo-controlled trial continuous intravenous diltiazem infusion heart rate control atrial fibrillation atrial flutter multicenter study safety efficacy continuous infusion intravenous diltiazem patients atrial fibrillation flutter mg mg bolus doses open label intravenous diltiazem patients bolus injection double-blind conditions continuous infusion intravenous diltiazem mg/h patients placebo patients Seventeen patients diltiazem infusion none placebo infusion therapeutic response patients diltiazem infusion response placebo infusion Nonresponders double-blind infusion additional bolus injection open label intravenous diltiazem open label intravenous diltiazem infusion overall proportion patients response infusion intravenous diltiazem double-blind open label conditions Efficacy infusion intravenous diltiazem similar elderly versus young patients digoxin versus equal kg intravenous diltiazem effective atrial fibrillation atrial flutter significant untoward effects